Below is a compiled list of scientific research and studies on Cannabidiol (CBD) and it’s potential use for treating Alzheimer’s Disease.

• Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer’s Disease
• Cannabidiol: a promising drug for neurodegenerative disorders?
• The role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses.
• Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
• The role of phytochemicals in the treatment and prevention of dementia.
• Neurological Aspects of Medical Use of Cannabidiol.
• Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model.
• Natural Phytochemicals in the Treatment and Prevention of Dementia
• Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression.
• Cannabinoids for the treatment of dementia.
• The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer’s disease.
• Endocannabinoid signalling in Alzheimer’s disease.
• Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
• Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells.